This year, we are proud to introduce a brand-new parallel stage: Trends House.
Its 2025 theme, ATMP Horizons, will spotlight the future of Advanced Therapy Medicinal Products (ATMPs) — from commissioning pathways to patient outcomes, from logistics to innovation governance.

Session Host

Oliver Brown, Project Lead - Advanced Therapies, LeadLife Sciences Hub Wales ·

Oliver leads the Advanced Therapies impact area at Life Sciences Hub Wales, where he connects innovations from industry, academia, and the NHS to address real-world healthcare challenges. With a background in pharmaceutical and supplement product development within CDMOs, Oliver has delivered a wide range of projects across multiple dosage forms and regulatory markets. He is passionate about driving transformative projects that improve health outcomes and accelerate innovation adoption in Wales.

Opening Keynote

Dr. Hannah Crocker
ATMP Outcomes Programme Manager, NHS Wales Joint Commissioning Committee (NWJCC)

Hannah brings her expertise in molecular biology, renal medicine, and gene therapies into her current leadership role at NHS Wales JCC. Her opening address will open the Trends House by framing how real-world data and patient-reported outcomes are transforming commissioning decisions and the delivery of ATMPs in Wales.

Spotlight Talks – From Discovery to Delivery: Making ATMPs System-Ready

• With industry perspectives from:
• Dr Andrew Roddam, Chief Business Development Officer, EveryONE Medicines
• Dr Tiago Magalhães, Vice President Bioinformatics M42 Health, UAE (online)

High-Level Panel Discussion – ATMP Horizons: Scaling Advanced Therapies for Global Health Impact,

With the Spotlight Talks speakers and:


• Dr Michelle Lam,  Medical Assessor, MHRA - Medicines and Healthcare products Regulatory Agency
• Linda Galbraith, Patient and Public Involvement and Engagement (PPIE) Chair for the International Alliance for Cancer Early Detection (ACED)